MTOR and neoplasm: Due to genetic mutations (PI3KCA, PTEN depletion, and receptor tyrosine kinase activation, etc) [37, 38], Akt-mTOR cascade is frequently hyper-activated in OS, contributing to tumor initiation and disease progression [7, 37–42].